MoonLake Immunotherapeutics MLTX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's change in AP?
- MoonLake Immunotherapeutics (MLTX) reported change in AP of -$6.17M in Q1 2026.
- How has MoonLake Immunotherapeutics's change in AP changed year-over-year?
- MoonLake Immunotherapeutics's change in AP decreased by 304.9% year-over-year, from $3.01M to -$6.17M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.